Once daily versus three times daily mesalazine granules in active ulcerative colitis: a double-blind, double-dummy, randomised, non-inferiority trial von Kruis, W, Kiudelis, G, Rácz, I, Gorelov, I A, Pokrotnieks, J, Horynski, M, Batovsky, M, Kykal, J, Boehm, S, Greinwald, R, Mueller, R

Volltext

3g mesalazine granules are superior to 9mg budesonide for achieving remission in active ulcerative colitis: A double-blind, double-dummy, randomised trial von Gross, Volker, Bunganic, Ivan, Belousova, Elena A., Mikhailova, Tatyana L., Kupcinskas, Limas, Kiudelis, Gediminas, Tulassay, Zsolt, Gabalec, Libor, Dorofeyev, Andrey E., Derova, Jelena, Dilger, Karin, Greinwald, Roland, Mueller, Ralph

Volltext

Once versus three times daily dosing of oral budesonide for active Crohn's disease: A double-blind, double-dummy, randomised trial von Dignass, Axel, Stoynov, Simeon, Dorofeyev, Andrey E., Grigorieva, Galina A., Tomsová, Eva, Altorjay, István, Tuculanu, Daniel, Bunganič, Ivan, Pokrotnieks, Juris, Kupčinskas, Limas, Dilger, Karin, Greinwald, Roland, Mueller, Ralph

Volltext

Evaluation of Gastroduodenal Disorders in NSAID Users due to Helicobacter pylori Status von Denapiene, G, Irnius, A, Venalis, A, Barakauskiene, A, Buineviciute, A, Cepuliene, I

Volltext

Crohn's disease in human immunodeficiency virus-infected patient: A case report von Vinikaite, Ausra, Kurlinkus, Benediktas, Jasinskaite, Dominyka, Strainiene, Sandra, Buineviciute, Audrone, Sadauskaite, Goda, Kiudelis, Vytautas, Kazenaite, Edita

Volltext

Crohn's disease in human immunodeficiency virus-infected patient: A case report von Vinikaite, Ausra, Kurlinkus, Benediktas, Jasinskaite, Dominyka, Strainiene, Sandra, Buineviciute, Audrone, Sadauskaite, Goda, Kiudelis, Vytautas, Kazenaite, Edita

Volltext